[1] |
Wong MJ, Dai YX, Ge JB. Pan-vascular disease: what we have done in the past and what we can do in the future? [J]. Cardiol Plus, 2024, 9(1): 1-5.
|
[2] |
中国医师协会心血管内科医师分会. 泛血管疾病抗栓治疗中国专家共识(2024版) [J]. 中华医学杂志, 2024, 104(12): 906-923.
|
[3] |
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet, 2020, 396(10258): 1223-1249.
|
[4] |
Almuwaqqat Z, Hui Q, Liu C, et al. Long-term body mass index variability and adverse cardiovascular outcomes [J]. JAMA Netw Open. 2024, 7(3): e243062.
|
[5] |
Massey RG, Siddiqui MK, Pearson ER, et al. Weight variability and cardiovascular outcomes: a systematic review and meta-analysis [J]. Cardiovasc Diabetol, 2023, 22(1): 5.
|
[6] |
Mehran L, Honarvar M, Masoumi S, et al. The association of body mass index variability with cardiovascular disease and mortality: a mediation analysis of pooled cohorts [J]. Front Endocrinol (Lausanne), 2024, 15: 1345781.
|
[7] |
Brownell KD, Greenwood MR, Stellar E, et al. The effects of repeated cycles of weight loss and regain in rats [J]. Physiol Behav, 1986, 38(4): 459-64.
|
[8] |
Lissner L, Odell PM, D'Agostino RB, et al. Variability of body weight and health outcomes in the Framingham population [J]. N Engl J Med, 1991, 324(26): 1839-1844.
|
[9] |
Ha J, Kwon Y, Kwon YJ, et al. Variability in body weight precedes diagnosis in dementia: A nationwide cohort study [J]. Brain Behav, 2020,10(11): e01811.
|
[10] |
杨雁, 陈颖, 张惠杰, 等. 糖尿病患者体重管理专家共识(2024版) [J]. 中华糖尿病杂志, 2024, 16(9): 959-971.
|
[11] |
Gallo G, Desideri G, Savoia G. Update on obesity and cardiovascular risk: from pathophysiology to clinical management[J]. Nutrients, 2024, 16(16): 2781.
|
[12] |
中华医学会内分泌学分会. 肥胖患者的长期体重管理及药物临床应用指南(2024版) [J]. 中华内分泌代谢杂志, 2024, 40(7): 545-564.
|
[13] |
Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement [J]. Eur Heart J, 2024, 45(38): 4063-4098.
|
[14] |
Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart disease and stroke statistics: A report of us and global data from the American Heart Association [J]. Circulation, 2024, 149(8): e347-e913.
|
[15] |
Almuwaqqat Z, Hui Q, Liu C, et al. Long-term body mass index variability and adverse cardiovascular outcomes [J]. JAMA Netw Open, 2024, 7(3): e243062.
|
[16] |
Bangalore S, Fayyad R, Laskey R, et al. Body-weight fluctuations and outcomes in coronary disease [J]. N Engl J Med, 2017, 376(14): 1332-1340.
|
[17] |
Kim DH, Nam GE, Han K, et al. Variabilities in weight and waist circumference and risk of myocardial infarction, stroke, and mortality: A nationwide cohort study [J]. Endocrinol Metab (Seoul), 2020, 35(4): 933-942.
|
[18] |
Nam GE, Kim W, Han K, et al. Body weight variability and the risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: A nationwide cohort study [J]. Diabetes Care, 2020, 43(9): 2234-2241.
|
[19] |
Huang S, Shi K, Ren Y, et al. Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: a systematic review and meta-analysis [J]. Cardiovasc Diabetol, 2022, 21(1): 78.
|
[20] |
Kazibwe R, Singleton MJ, Ahmad MI, et al. Association between weight variability, weight change and clinical outcomes in hypertension [J]. Am J Prev Cardiol, 2023, 16: 100610.
|
[21] |
Li Y, Yu Y, Wu Y, et al. Association of body-weight fluctuation with outcomes in heart failure with preserved ejection fraction [J]. Front Cardiovasc Med, 2021, 8: 689591.
|
[22] |
Turicchi J, O'Driscoll R, Horgan, G, et al. Body weight variability is not associated with changes in risk factors for cardiometabolic disease [J]. Int J Cardiol Hypertens, 2020, 6: 100045.
|
[23] |
Sarin HV, Lee JH, Jauhiainen M, et al. Substantial fat mass loss reduces low-grade inflammation and induces positive alteration in cardiometabolic factors in normal-weight individuals [J]. Sci Rep, 2019, 9(1): 3450.
|
[24] |
Manemann SM, Bielinski SJ, Moser ED, et al. Variability in lipid levels and risk for cardiovascular disease: An electronic health record-based population cohort study [J]. J Am Heart Assoc, 2023, 12(5): e027639.
|
[25] |
Goldstein LB. Weighing the effect of overweight/obesity on stroke risk [J]. Stroke, 2024, 55(7): 1866-1868.
|
[26] |
Lu J, Gong S, Zhu J, et al. Relationships between obesity and functional outcome after ischemic stroke: a Mendelian randomization study [J]. Neurol Sci, 2024, 45(8): 3869-3877.
|
[27] |
Kim MK, Han K, Park YM, et al. Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population [J]. Circulation, 2018, 138: 2627-2637.
|
[28] |
Ceriello A, Lucisano G, Prattichizzo F, et al. Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register [J]. Cardiovasc Diabetol, 2021; 20(1): 173.
|
[29] |
Bangalore S, Fayyad R, DeMicco DA, et al. Body weight variability and cardiovascular outcomes in patients with type 2 diabetes mellitus [J]. Circ Cardiovasc Qual Outcomes, 2018, 11(11): e004724.
|
[30] |
Bhadada SK, Malhotra B, Shetty AJ. Body Weight Variability and Cardiovascular Health in Diabetes [J]. J Clin Endocrinol Metab, 2023, 108(2): e19-e20.
|
[31] |
Kaze AD, Santhanam P, Erqou S, et al. Body weight variability and risk of cardiovascular outcomes and death in the context of weight loss intervention among patients with type 2 diabete s[J]. JAMA Netw Open, 2022, 5(2): e220055.
|
[32] |
Zonneveld MH, Noordam R, Sabayan B, et al. Weight loss, visit-to-visit body weight variability and cognitive function in older individuals [J]. Age Ageing, 2023, 52(1): afac312.
|
[33] |
Park Y, Kim SH, Ryu J, et al. Association of midlife body-weight variability and cycles with earlier dementia onset: a nationwide cohort study [J]. Alzheimers Res Ther, 2024,16(1): 91.
|
[34] |
Park S, Jeon SM, Jung SY, et al. Effect of late-life weight change on dementia incidence: a 10-year cohort study using claim data in Korea [J]. BMJ Open, 2019, 9(5): e021739.
|
[35] |
Chandrasekaran P, Weiskirchen R. The role of obesity in type 2 diabetes mellitus-an overview [J]. Int J Mol Sci, 2024, 25(3): 1882.
|
[36] |
Prattichizzo F, Veronesi V, Rigoni M, et al. Body weight variability as a predictor of cardiovascular outcomes in type 1 diabetes: A nationwide cohort study [J]. Diabetes Obes Metab, 2024, 12:1-11.
|
[37] |
Mehran L, Mousapour P, Khalili D, et al. BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS) [J]. Sci Rep, 2022, 12(1): 18370.
|
[38] |
Massey RJ, Chen Y, Panova-Noeva M, et al. BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study [J]. Cardiovasc Diabetol, 2024, 23(1): 256.
|
[39] |
Hukportie DN, Li FR, Zhou R, et al. Waist circumference and body mass index variability and incident diabetic microvascular complications: A post hoc analysis of ACCORD trial [J]. Diabetes Metab J, 2022 ,46(5): 767-780.
|
[40] |
方雍乔, 汪文俊, 刘欢欢, 等. 2型糖尿病患者体重变异性与糖尿病肾病发病风险的相关性 [J]. 中华医学杂志, 2024, 104(10): 742-750.
|
[41] |
Nystrom T, Andersson Franko M, Ludvigsson J, et al. Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes [J]. Diabetes Obes Metab, 2024, 26(6): 2509-2512.
|
[42] |
Okada H, Hamaguchi M, Habu M, et al. Association between variability in body mass index and development of type 2 diabetes: Panasonic cohort study [J]. BMJ Open Diabetes Res Care, 2021, 9(1): e002123.
|
[43] |
Sea MM, Fong WP, Huang Y, et al. Weight cycling-induced alteration in fatty acid metabolism [J]. Am J Physiol Regul Integr Comp Physiol, 2000, 279(3): R1145-1155.
|
[44] |
Park MJ, Yoo J, Han K, et al. High body weight variability is associated with increased risk of depression: a nationwide cohort study in South Korea [J]. Psychol Med, 2023, 53(8): 3719-3727.
|
[45] |
Guo TS, Zheng SR, Chen T, et al. The association of long-term trajectories of BMI, its variability, and metabolic syndrome: a 30-year prospective cohort study [J]. E Clinical Medicine, 2024, 69: 102486.
|
[46] |
Yao H, Zhang A, Li D, et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis [J]. BMJ, 2024, 384: e076410.
|
[47] |
颜宥彤, 赵锐, 万谦益, 等. GLP-1受体激动剂——司美格鲁肽的应用及安全性 [J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(2): 88-93.
|